MedTrace Logo

Postoperative Analgesic Efficacy of SPSIPB in Anterior Cervical Discectomy

NCT07238621 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-02-25

No results posted yet for this study

Summary

Anterior cervical discectomy is an operation performed for complaints of pain, numbness or loss of strength due to cervical disc disease. With this operation, pressure due to herniation on the upper neck area, spinal cord or nerve roots is relieved. It is performed by microscopic method from the front of the neck.

Nerve blocks reduces opioid consumption in the postoperative period by providing better pain control and therefore has advantages such as fewer side effects and less risk of pulmonary and cardiac complications.

In this study; it was aimed to compare the analgesic effectiveness of serratus posterior superior intercostal plane block and erector spinae plane block, and with the control group in the postoperative period in patients who underwent anterior cervical discectomy.

Conditions

  • Anterior Cervical Discectomy
  • Serratus Posterior Superior Intercostal Plane Block
  • Postoperative Pain Management
  • Postoperative Pain
  • Cervical Disc Herniation

Interventions

PROCEDURE

The group treated with intravenous analgesics

In the postoperative period a ibuprofen dose of 400 mg every 8 hours were administered iv for multimodal analgesia

PROCEDURE

Serratus posterior superior intercostal plane block

Serratus posterior superior intercostal plane block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance.Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.

Sponsors & Collaborators

  • Cumhuriyet University

    lead OTHER

Principal Investigators

  • ONUR AVCI · Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation

  • ZEYNEP M DEMİRCİ · Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-10-10
Completion
2026-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07238621 on ClinicalTrials.gov